These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8587164)

  • 81. Effect of clavulanic acid on the anti-pseudomonal activity of ticarcillin.
    Haverkorn MJ
    Eur J Clin Microbiol Infect Dis; 1994 Aug; 13(8):692-3. PubMed ID: 7813509
    [No Abstract]   [Full Text] [Related]  

  • 82. Pharmacokinetics and serum bactericidal activity of ticarcillin and clavulanic acid.
    Höffken G; Tetzel H; Koeppe P; Lode H
    J Antimicrob Chemother; 1985 Dec; 16(6):763-71. PubMed ID: 4093345
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Current antimicrobial agent series II: Ticarcillin].
    Ueda Y
    Jpn J Antibiot; 1988 Jul; 41(7):761-81. PubMed ID: 3050182
    [No Abstract]   [Full Text] [Related]  

  • 84. Overcoming Beta-Lactamase-Based Antimicrobial Resistance by Nanocarrier-Loaded Clavulanic Acid and Antibiotic Cotreatments.
    Filby BW; Weldrick PJ; Paunov VN
    ACS Appl Bio Mater; 2022 Aug; 5(8):3826-3840. PubMed ID: 35819369
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Ticarcillin-clavulanic acid zone size criteria.
    Poupard JA; Wester B
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2352. PubMed ID: 1444319
    [No Abstract]   [Full Text] [Related]  

  • 86. Efficacy of clavulanate-potentiated antibiotics against Bacteroides species and artificially associated cultures of aerobes and anaerobes.
    Werner H; Heizmann WR; Freuer G; Mitinis N; Heilmann F
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():55-61. PubMed ID: 2606820
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The effect of varying ratios of ticarcillin to clavulanic acid against gentamicin-resistant and gentamicin-sensitive Enterobacteriaceae.
    Wheat PF; Spencer RC
    J Antimicrob Chemother; 1984 Aug; 14(2):195-6. PubMed ID: 6568225
    [No Abstract]   [Full Text] [Related]  

  • 88. Piperacillin against clinical isolates: antimicrobial profile and clinical role.
    McAllister TA
    J Antimicrob Chemother; 1982 Feb; 9 Suppl B():75-84. PubMed ID: 6460736
    [No Abstract]   [Full Text] [Related]  

  • 89. Proposed ticarcillin disk control values for Escherichia coli and Pseudomonas aeruginosa: multicenter cooperative study.
    Prior RB; Fass RJ
    Antimicrob Agents Chemother; 1978 Sep; 14(3):507-8. PubMed ID: 101134
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Clinical effects of a combination treatment with fosfomycin and clavulanic acid/ticarcillin for infections in patients complicated with hematological disorders].
    Hirakawa K; Tsuda S; Misawa S; Ueda Y; Kaneko H; Nakao M; Ariyama Y; Nakai H; Seriu T; Takashima T
    Jpn J Antibiot; 1994 May; 47(5):521-9. PubMed ID: 8051794
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Comparative epidemiology of the resistance of enterobacteriaceae, Staphylococcus and Pseudomonas aeruginosa to fluoroquinolones in an outpatient study].
    Weber P; Plaisance JJ; Mancy C
    Presse Med; 1995 Jun; 24(21):979-82. PubMed ID: 7667220
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Susceptibility testing recommendations for ticarcillin/clavulanic acid in the Stokes' disc diffusion test.
    Sutherland R
    J Antimicrob Chemother; 1989 Sep; 24(3):463-4. PubMed ID: 2808198
    [No Abstract]   [Full Text] [Related]  

  • 93. Ticarcillin/clavulanate in the treatment of severe peritonitis.
    Inthorn D; Mühlbayer D; Hartl WH
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():141-6. PubMed ID: 2691475
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function.
    Jungbluth GL; Cooper DL; Doyle GD; Chudzik GM; Jusko WJ
    Antimicrob Agents Chemother; 1986 Dec; 30(6):896-900. PubMed ID: 3492959
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The characteristics of genetically related Pseudomonas aeruginosa from diverse sources and their interaction with human cell lines.
    Streeter K; Neuman C; Thompson J; Hatje E; Katouli M
    Can J Microbiol; 2016 Mar; 62(3):233-40. PubMed ID: 26854365
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comparative aminoglycoside inactivation by potassium clavulanate.
    Courcol RJ; Martin GR
    J Antimicrob Chemother; 1986 May; 17(5):682-4. PubMed ID: 3722038
    [No Abstract]   [Full Text] [Related]  

  • 97. Positive direct antiglobulin tests due to clavulanic acid.
    Williams ME; Thomas D; Harman CP; Mintz PD; Donowitz GR
    Antimicrob Agents Chemother; 1985 Jan; 27(1):125-7. PubMed ID: 3872623
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A reassessment of ticarcillin/clavulanic acid dose recommendations for infants, children and adults.
    Reed MD
    Pediatr Infect Dis J; 1998 Dec; 17(12):1195-9. PubMed ID: 9877382
    [No Abstract]   [Full Text] [Related]  

  • 99. Synergy of clavulanic acid with benzylpenicillin or cephalothin against Yersinia spp.
    Jimenez-Valera M; Ruiz-Bravo A; Ramos-Cormenzana A
    J Antimicrob Chemother; 1987 Jun; 19(6):845-7. PubMed ID: 3497153
    [No Abstract]   [Full Text] [Related]  

  • 100. Synthesis and beta-lactamase inhibitory activity of 9-(2-amidoethenylthio)-9-deoxy derivatives of clavulanic acid.
    Brooks G; Coleman K; Davies JS; Hunter PA
    J Antibiot (Tokyo); 1988 Jul; 41(7):892-8. PubMed ID: 3262103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.